Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2005
07/14/2005CA2550435A1 Azabicyclic heterocycles as cannabinoid receptor modulators
07/14/2005CA2550375A1 Azabicyclic heterocycles as cannabinoid receptor modulators
07/14/2005CA2548326A1 Bicyclic heterocyclic p-38 kinase inhibitors
07/13/2005EP1553179A1 Mouse-origin proteins forming domain or use thereof
07/13/2005EP1553096A1 Pyrazole compounds
07/13/2005EP1553085A1 Cyclic amine derivatives and their use as drugs
07/13/2005EP1552813A1 Hair dyeing composition comprising a fluorindinium compound.
07/13/2005EP1551843A1 Diazabicyclic compounds useful in the treatment of cns and other disorders
07/13/2005EP1551842A1 Pyradazine compounds as gsk-3 inhibitors
07/13/2005EP1551841A1 Pyrazolopyrimidines as kinase inhibitors
07/13/2005EP1551840A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
07/13/2005EP1551812A2 Mitotic kinesin inhibitors
07/13/2005EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
07/13/2005EP1551809A1 Pyrazole compounds for treatment of neurodegenerative disorders
07/13/2005EP1551511A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/13/2005EP1551410A2 Novel compounds
07/13/2005EP1551398A1 Pyrazolopyridines and methods of making and using the same
07/13/2005EP1551384A2 R-nsaid esters and their use
07/13/2005EP1242424B1 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives
07/13/2005EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity
07/13/2005EP1171443B1 Bicyclic heteroaromatic compounds useful as lh agonists
07/13/2005EP1066291B1 Fungicidal 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidines
07/13/2005EP0977755B1 Heterocyclic compounds and their preparation and use
07/13/2005CN1639178A Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
07/13/2005CN1639168A Bicyclic pyridine and pyrimidine P38 kinase inhibitors
07/13/2005CN1639166A Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography
07/13/2005CN1639165A Purine derivatives as kinase inhibitors
07/13/2005CN1639164A Nitrogen-containing heterocyclic compound
07/13/2005CN1639130A Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
07/13/2005CN1638776A Substituted 3-aryl-5-aryl-[1, 2, 4]-oxadiazoles and analogs
07/13/2005CN1638775A Nitric oxide donors for treatment of disease and injury
07/13/2005CN1638774A Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
07/13/2005CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
07/13/2005CN1636996A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
07/13/2005CN1636597A Compounds for the treatment of female sexual dysfunction
07/13/2005CN1210277C Heteroaryl diazabicycloalkanes, their prepn. and use
07/13/2005CN1210276C Plant extractive and alkaloid with cough-relieving activity
07/13/2005CN1210274C Piperazine and piperidine derivatives
07/13/2005CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use
07/12/2005US6916982 For solar cells; good solubility; wide spectral coverage; polymerizing the ethynyl-modified porphyrin monomers
07/12/2005US6916957 Antiinflammatory agents; antihistamines; antiallergens
07/12/2005US6916927 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction
07/12/2005US6916923 Method for synthesizing pyrazolobenzodiazepines
07/12/2005US6916922 Acylating a cyclopentaindolemethylamine and cyclizing and reducing the product
07/12/2005US6916818 Nitrogen compounds such as 1-(1-Naphthalenesulfonyl)-3-(octa-hydro-4-quinolizinyl)-1H-5-azaindole, used as serotonin receptor antagonists for prophylaxis of psychological disorders
07/12/2005US6916815 C-6 modified indazolylpyrrolotriazines
07/12/2005US6916811 Adenosine A2a receptor antagonists
07/12/2005US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme
07/12/2005US6916807 Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
07/12/2005US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use
07/12/2005US6916799 Antiinflammatory agents; respiratory system disorders
07/12/2005CA2349142C Compositions and methods for stimulating gastrointestinal motility
07/12/2005CA2323008C Pharmaceutically active compounds
07/12/2005CA2175054C 2-(pyrazol-3-yl)carbapenem derivatives
07/12/2005CA2143040C The use of benzazoles as uv absorbers, new benzazoles and a process for their preparation
07/07/2005WO2005061519A1 Kinase inhibitors
07/07/2005WO2005061513A1 Polycyclic agents for the treatment of respiratory syncytial virus infections
07/07/2005WO2005061512A1 Spiro-condensed indoline derivates as pesticides
07/07/2005WO2005061511A1 Nicotinic acetylcholine receptor ligands
07/07/2005WO2005061510A1 Nicotinic acetylcholine receptor ligands
07/07/2005WO2005061509A1 Azabicyclic heterocycles as cannabinoid receptor modulators
07/07/2005WO2005061508A1 Tricyclic heterocyclic compound and medicine containing the compound as active ingredient
07/07/2005WO2005061507A1 Bicyclic pyrazol-4-one cannabinoid receptor ligands and uses thereof
07/07/2005WO2005061506A1 Bicyclic pyrazolyl and imidazolyl compounds as cannabinoid receptor ligands and uses thereof
07/07/2005WO2005061505A1 Bicyclic imidazolyl pyrimidin-4-one cannabinoid receptor ligands and uses thereof
07/07/2005WO2005061504A1 Bicyclic pyridazinone cannabinoid receptor ligands and uses thereof
07/07/2005WO2005061503A1 Triazolopyrimidines with fungicidal properties
07/07/2005WO2005061502A1 6-(aminocarbonyl-phenyl) triazolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same
07/07/2005WO2005061501A2 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
07/07/2005WO2005061466A1 Novel phenylalanine derivative
07/07/2005WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
07/07/2005WO2005049593A3 N-acylsulfonamide apoptosis promoters
07/07/2005WO2005040160A3 Processes for preparation of ziprasidone
07/07/2005WO2005037783A3 Use of tricyclic compounds as glycine transport inhibitors
07/07/2005WO2005021025A3 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION
07/07/2005WO2004058704A3 Quinazolinones as potassium channel modulators
07/07/2005WO2004022560A9 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
07/07/2005US20050148772 Methods and compositions for detecting polynucleotide duplex damage and errors
07/07/2005US20050148768 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
07/07/2005US20050148651 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl-(amine- derived)] compounds and analogues thereof, and to products obtained therefrom
07/07/2005US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals
07/07/2005US20050148610 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
07/07/2005US20050148609 Tetrazole substituted quinazoline compounds for antiproliferation agents
07/07/2005US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs
07/07/2005US20050148604 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases
07/07/2005US20050148603 Compositions useful as inhibitors of protein kinases
07/07/2005US20050148602 Inhibitors of alphaLbeta2 mediated cell adhesion
07/07/2005US20050148593 Compounds, compositions, and methods
07/07/2005US20050148591 Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen and pharmaceutical compositions thereof
07/07/2005US20050148586 Quinoxalinones
07/07/2005US20050148575 (Di)Azepino[5,4,3-cd]benzothiophenes; poly(ADP-ribose) polymerase (PARP) and glycohydrolase (PARG) inhibitor; antiinflammatory; protects cells, tissue and organs against the ill-effects of reactive free radicals and nitric oxide, and damage following focal ischemia and reperfusion injury
07/07/2005DE10358539A1 Carbonsäureamidderivate Carboxamide
07/07/2005DE10357570A1 New 7-amino-5-halo-pyrazolo-(1,5-a)-pyrimidine derivatives, useful as microbicides, especially fungicides or bactericides for protecting plants or materials such as wood
07/07/2005DE10357569A1 Pyrazolopyrimidine Pyrazolopyrimidines
07/07/2005DE10357568A1 Pyrazolopyrimidine Pyrazolopyrimidines
07/07/2005DE10357567A1 Pyrazolopyrimidine Pyrazolopyrimidines
07/07/2005DE10357566A1 Pyrazolopyrimidine Pyrazolopyrimidines
07/07/2005DE10357565A1 Pyrazolopyrimidine Pyrazolopyrimidines
07/07/2005DE10356579A1 Aminderivate Amine derivatives
07/07/2005DE10356184A1 Zeolithisches Material vom Pentasil-Strukturtyp, seine Herstellung und seine Verwendung Zeolitic material of the pentasil structure type, its preparation and its use